CLINICAL_TRIALS
withdrawal
· 2024-08-23
Clinical Trial Update: Pharmacokinetics, Efficacy, Tolerability and Safety of Different Budesonide Oral Gel Doses in Adults' Subjects of Both Genders With Eosinophilic Esophagitis (EoE) [Phase 2]
Summary
Phase 2 trial evaluating pharmacokinetics, efficacy, tolerability, and safety of different budesonide oral gel doses in adults with eosinophilic esophagitis was…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bazell Pharma AG | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: WITHDRAWN